POLICY MAKERS

Migraine Atlas by AEMICE

AEMICE together with Universidad de Sevilla (Seville University) and Novartis and a scientific committee of expert neurologists has created the Migraine Atlas by AEMICE 2018 which reflects the real situation of the 4.5 million people who suffer from migraine in Spain! Unlike other studies “Migraine Atlas” includes the patients and also their families perspective about their condition, […]

Migraine Atlas by AEMICE Read More »

Migraine and teenagers

11.3% of Spanish teenagers suffer from migraine headaches Migraine and teenagers The journal Cephalalgia – the scientific publication of the International Society of Headaches – has just published a study by members of the Headache Study Group of the Spanish Society of Neurology (SEN) of the Vall D’Hebron University Hospital, whose Objective was to evaluate

Migraine and teenagers Read More »

European Patients’ Rights Day, TODAY, April 18

Patients claim their right to participate in Decision about their Health Patients have the right to participate in making decisions about their health, either through patient organizations in public policies that affect them or through the sharing of information and consensus with their doctor, for example, about what treatment to follow. This is one of

European Patients’ Rights Day, TODAY, April 18 Read More »

PRAC recommends new measures to avoid valproate exposure in pregnancy

The European Medicines Agency’s experts in medicines safety, the Pharmacovigilance Risk Assessment Committee (PRAC) are recommending new measures to avoid exposure of babies to valproate medicines in the womb. Babies exposed are at risk of malformations and developmental problems. The PRAC examined the available evidence and consulted widely with healthcare professionals and with patients, including women

PRAC recommends new measures to avoid valproate exposure in pregnancy Read More »

Scroll to Top
Search
Close this search box.

Join our newsletter.

Don't miss out on any updates! Join our community and discover 

the latest research, treatments, and events on migraine.
Subscribe now!

"*" indicates required fields

Email Adress*
Name*